Groningen advances in antibiotics research

Groningen advances in antibiotics research

Groningen advances in antibiotics research

Wed, 31 May 2017

Controlling antibiotic activity by light. Nobel Prize winner Ben Feringa and his colleagues on Campus Groningen developed
this method, allowing the precise activation of antibiotics while avoiding collateral killing of human microbiota and
spreading of resistance. “This is a whole new way of thinking about drug research’’, says the laureate. And this out-of-the-box thinking is exactly what makes Campus Groningen stand out.

The ‘triple helix’ model of collaboration between companies, governments and knowledge institutes is commonplace at Campus Groningen. Researchers on this Campus work at the forefront of fundamental and applied knowledge, in multiple societal impact fields. The Campus gains worldwide attention for its ability to discover, develop and test new types of drugs, of which antibiotics are one of the most eye-catching.

The development of new drugs, from discovery to clinical testing, all taking place on Campus Groningen, the innovation engine of the Northern Netherlands.

Read the whole article here.